Mortality in epilepsy remains an area of concern that brings together scientists, clinicians and families/advocates with a shared goal of preventing mortality. This meeting provides a forum the aim of which is to prevent mortality in epilepsy. This rigorous scientific meeting will
- Promote understanding of the latest developments in SUDEP and epilepsy mortality research,
- Stimulate ideas and collaborations to advance discovery,
- Hasten efforts to increase public awareness and education for professionals and people living with epilepsy.
Clinicians will improve their competence related to discussions of epilepsy related mortality, including risk factors and prevention strategies.
Researchers will identify goals for future research and build collaborations with other scientists as well as clinicians and families/advocates.
Families/advocates will learn about research and will advance SUDEP awareness and education by facilitating collaborations between support groups, funding sources, health care professionals and others. Families will share their stories and be provided opportunities to provide support to one another.
- Utilize awareness and knowledge of research in other disciplines when developing hypotheses related to premature mortality associated with epilepsy.
- Identify risk factors for epilepsy-related mortality and mitigate them.
- Routinely counsel patients and families regarding risks of mortality, especially SUDEP.
Neurologists, epileptologists, nurses, other healthcare-related professionals and families.
POLICY ON COMMERCIAL SUPPORT AND CONFLICT OF INTEREST
The American Epilepsy Society maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the AES provide in-depth presentations that are fair, balanced, independent and scientifically rigorous. All faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to the activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentations. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. This information will also be made available through syllabus materials and faculty presentations.
DISCLOSURE OF UNLABELED/UNAPPROVED USES
This educational program may include references to the use of products for indications not approved by the FDA. These discussions are noted on the faculty’s disclosure forms as well as during their presentations. Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by the American Epilepsy Society or any other manufacturers of pharmaceuticals.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Epilepsy Society (AES) and the Sudden Unexpected Death In Epilepsy (SUDEP) Partners [which includes the Centers for Disease Control (CDC), Citizens United for Research in Epilepsy (CURE), the Epilepsy Foundation of America/Epilepsy Therapy Project (EFA/ETP), Finding a Cure for Epilepsy and Seizures (FACES), the National Institute of Neurological Disorders and Stroke (NINDS), and SUDEP Aware)]. The AES is accredited by the ACCME to provide continuing medical education for physicians.
Physicians: The American Epilepsy Society designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Projects In Knowledge is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is co-provided by Projects In Knowledge and the American Epilepsy Society. This activity is awarded up to 17.25 contact hours.